Skip to Main Content

Peripheral Blood Profiling to Screen Patients for Lung Cancer or Lung Cancer Recurrence

Conditions

Diseases of the Respiratory System

What is the purpose of this trial?

The purpose of this study is to screen patients at risk for lung cancer, or lung cancer recurrence using a novel sequencing technique to detect fragments of mutated DNA in the peripheral blood.

  • Trial with
    Yale University School of Medicine
  • Start Date
    09/02/2014
  • End Date
    09/29/2024
Trial Image

For more information about this study, contact:

Kristine Tyc

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/22/2018
  • Study HIC
    #1407014379